Literature DB >> 19127078

Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.

Shunichi Matsuoka1, Kazushige Nirei, Akinori Tamura, Hitomi Nakamura, Hiroshi Matsumura, Shuu Oshiro, Yasuo Arakawa, Hiroaki Yamagami, Naohide Tanaka, Mitsuhiko Moriyama.   

Abstract

We examined prospectively the influence of occult hepatitis B virus (HBV) infection on the histopathological features and clinical outcome of HCV RNA-positive chronic hepatitis (CH-C) and detected hepatitis B core (HBc) particles in hepatocytes. The subjects were 468 patients with CH-C or liver cirrhosis (LC) who were negative for serum hepatitis B surface antigen (HBsAg) by enzyme-linked immunosorbent assay. HBV DNA was detected in serum by nested PCR. HBsAg and HBc antigen (HBcAg) in liver were investigated using immunohistochemical techniques and light (LM) and electron microscopy (EM). Serum HBV DNA was detected in 43.6% of the patients studied. There were no significant differences between HBV DNA-positive and DNA-negative patients in terms of their clinical profiles. For HBV DNA-positive patients, the degree of inflammatory cell infiltration and irregular regeneration of hepatocytes was significantly greater than for HBV DNA-negative patients. The cumulative probability of development of hepatocellular carcinoma (HCC) was significantly higher for HBV DNA-positive patients than for HBV DNA-negative patients. HBV DNA positivity was a risk factor for the occurrence of HCC according to multivariate analysis. HBsAg and HBcAg were detected in 8.5 and 72.3%, respectively, of the livers of serum HBV DNA-positive individuals. Core particles were detected in the nuclei of the hepatocytes by IEM. The histopathological features and long-term outcome of CH-C or LC could be affected by occult HBV infection. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127078     DOI: 10.1159/000187720

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  27 in total

1.  Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Arvind Reddy; Elizabeth May; Murray Ehrinpreis; Milton Mutchnick
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors:  Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal:  World J Hepatol       Date:  2015-03-27

3.  Establishing the link between hepatitis B virus infection and colorectal adenoma.

Authors:  Brijesh B Patel; Seth Lipka; Huafeng Shen; Ashley H Davis-Yadley; Prakash Viswanathan
Journal:  J Gastrointest Oncol       Date:  2015-10

Review 4.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

5.  Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study.

Authors:  Naoko Tsubouchi; Hirofumi Uto; Kotaro Kumagai; Fumisato Sasaki; Shuji Kanmura; Masatsugu Numata; Akihiro Moriuchi; Makoto Oketani; Akio Ido; Katsuhiro Hayashi; Kazunori Kusumoto; Kazuya Shimoda; Sherri O Stuver; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2013-02-18       Impact factor: 4.288

6.  Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

Authors:  Anna S Lok; James E Everhart; Adrian M Di Bisceglie; Hae-Young Kim; Munira Hussain; Timothy R Morgan
Journal:  Hepatology       Date:  2011-08       Impact factor: 17.425

Review 7.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 8.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Authors:  C M Martin; J A Welge; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2012-06-04       Impact factor: 3.728

Review 10.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.